Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial looked at a drug called talactoferrin for non small cell lung cancer that has got worse despite treatment.
Recruitment start: 1 June 2009
Recruitment end: 2 March 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Yvonne Summers
Agennix Incorporated
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 30 Sept 2014
CRUK internal database number: 5648
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
